Ulcerative Colitis

Eli Lilly's LY4268989 Study with Mirikizumab in Ulcerative Colitis Underway

A clinical trial is evaluating the safety and effectiveness of LY4268989 co-administered with mirikizumab in adults with moderately to severely active ulcerative colitis.

Boomerang Medical initiates pivotal trial for device in ulcerative colitis

Boomerang Medical is conducting a pivotal trial to evaluate a device aimed at reducing bowel urgency in ulcerative colitis patients.

Phase III Trial of Hemay005 in Chinese Patients with Ulcerative Colitis Initiated

A phase III trial has been initiated to evaluate Hemay005 for the treatment of moderately to severely active ulcerative colitis in Chinese patients.

Pfizer's Phase 3 Study of Tofacitinib in Pediatric Ulcerative Colitis Underway

Phase 3 Study of Duvakitug for Moderately to Severely Active Ulcerative Colitis Initiated

A Phase 3 maintenance study is underway to evaluate duvakitug's efficacy and safety in patients with moderately to severely active Ulcerative Colitis.